Common use of Study Population Clause in Contracts

Study Population. The study population in this protocol is comprised of otherwise healthy ambulatory postmenopausal women who: 1. have participated in Study BA058-05-003, 2. were randomized to either Abaloparatide/Placebo, 3. have completed the End-of-Treatment Visit (Visit 9 in Study BA058-05-003), and 4. have provided a new written informed consent for this protocol. Subjects will not be enrolled if they experienced treatment-related SAE or were withdrawn from Study BA058-05-003 for any reason.

Study Population. The study population in this protocol is comprised of otherwise healthy ambulatory postmenopausal women who: 1. have participated in Study BA058-05-003, 2. were randomized to either AbaloparatideBA058 Injection 80 µg/Placebo, 3. have completed the End-of-Treatment Visit (Visit 9 in Study BA058-05-003), and 4. have provided a new written informed consent for this protocol. Subjects will not be enrolled if they experienced treatment-related SAE or were withdrawn from Study BA058-05-003 for any reason.

Study Population. The study population in this protocol is comprised of otherwise healthy ambulatory postmenopausal women who: 1. have participated in Study BA058-05-003, , 2. were randomized to either Abaloparatide/Placebo, 3. have completed the End-of-Treatment Visit (Visit 9 in Study BA058-05-003), and 4. have provided a new written informed consent for this protocol. Subjects will not be enrolled if they experienced treatment-related SAE or were withdrawn from Study BA058-05-003 for any reason.

Study Population. The study population in this protocol is comprised of otherwise healthy ambulatory postmenopausal women who: 1. have participated in Study BA058-05-003, , 2. were randomized to either AbaloparatideBA058 Injection 80 µg/Placebo, 3. have completed the End-of-Treatment Visit (Visit 9 in Study BA058-05-003), and 4. have provided a new written informed consent for this protocol. Subjects will not be enrolled if they experienced treatment-related SAE or were withdrawn from Study BA058-05-003 for any reason.